Chapter 21 Flavivirus Encephalitides

  1. Tomori O: Yellow fever: the recurring plague. Crit Rev Clin Lab Sci 41(4):391–427, 2004. PUBMED Abstract
  2. Grebely J, Dore GJ: What is killing people with hepatitis C virus infection? Semin Liver Dis 31(4):331–339, 2011. PUBMED Abstract
  3. ICTV Master Species List 2009: Version 10, ed 10, International Committee on Taxonomy of Viruses, 2011.
  4. Gould EA, Solomon T: Pathogenic flaviviruses. Lancet 371(9611):500–509, 2008. PUBMED Abstract
  5. Mackenzie JS, Lindsay MD, Coelen RJ, et al: Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 136(3-4):447–467, 1994. PUBMED Abstract
  6. Mackenzie JS, Smith DW, Broom AK, et al: Australian encephalitis in Western Australia, 1978-1991. Med J Aust 158(9):591–595, 1993. PUBMED Abstract
  7. Mackenzie JS: Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania. J Neurovirol 11(5):434–440, 2005. PUBMED Abstract
  8. Lindenbach BD, Thiel H-J, Rice CM: Flaviviridae: the viruses and their replication. In Knipe DM, Howley PM, editors: Fields virology, ed 5, Philadelphia, 2007, Lippincott-Raven, pp 1101–1152.
  9. Li L, Lok SM, Yu IM, et al: The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319(5871):1830–1834, 2008. PUBMED Abstract
  10. Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3(1):13–22, 2005. PUBMED Abstract
  11. Rice CM, Lenches EM, Eddy SR, et al: Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229(4715):726–733, 1985. PUBMED Abstract
  12. Lanciotti RS, Roehrig JT, Deubel V, et al: Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286(5448):2333–2337, 1999. PUBMED Abstract
  13. Wengler G: Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol 63(6):2521–2526, 1989. PUBMED Abstract
  14. Grun JB, Brinton MA: Separation of functional West Nile virus replication complexes from intracellular membrane fragments. J Gen Virol 69(Pt 12):3121–3127, 1988. PUBMED Abstract
  15. Wengler G, Nowak T, Wahn K: Analysis of the influence of proteolytic cleavage on the structural organization of the surface of the West Nile flavivirus leads to the isolation of a protease-resistant E protein oligomer from the viral surface. Virology 160(1):210–219, 1987. PUBMED Abstract
  16. Nowak T, Wengler G: Analysis of disulfides present in the membrane proteins of the West Nile flavivirus. Virology 156(1):127–137, 1987. PUBMED Abstract
  17. Castle E, Nowak T, Leidner U, et al: Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus West Nile virus and of the genome sequence for these proteins. Virology 145(2):227–236, 1985. PUBMED Abstract
  18. Wengler G, Castle E, Leidner U, et al: Sequence analysis of the membrane protein V3 of the flavivirus West Nile virus and of its gene. Virology 147(2):264–274, 1985. PUBMED Abstract
  19. Colpitts TM, Barthel S, Wang P, et al: Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. PLoS One 6(9):e24365, 2011. PUBMED Abstract
  20. Schlick P, Kofler RM, Schittl B, et al: Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations. Vaccine 28(36):5903–5909, 2010. PUBMED Abstract
  21. Brault JB, Kudelko M, Vidalain PO, et al: The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication. Virology 417(2):369–378, 2010.
  22. Beasley DW, Whiteman MC, Zhang S, et al: Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J Virol 79(13):8339–8347, 2005. PUBMED Abstract
  23. Castle E, Leidner U, Nowak T, et al: Primary structure of the West Nile flavivirus genome region coding for all nonstructural proteins. Virology 149(1):10–26, 1986. PUBMED Abstract
  24. Roehrig JT, Bolin RA, Kelly RG: Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246(2):317–328, 1998. PUBMED Abstract
  25. Koschinski A, Wengler G, Repp H: The membrane proteins of flaviviruses form ion-permeable pores in the target membrane after fusion: identification of the pores and analysis of their possible role in virus infection. J Gen Virol 84(Pt 7):1711–1721, 2003. PUBMED Abstract
  26. Yamshchikov VF, Trent DW, Compans RW: Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components. J Virol 71(6):4364–4371, 1997. PUBMED Abstract
  27. Liu WJ, Chen HB, Wang XJ, et al: Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 78(22):12225–12235, 2004. PUBMED Abstract
  28. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, et al: Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79(13):8004–8013, 2005. PUBMED Abstract
  29. Grun JB, Brinton MA: Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity. J Virol 61(11):3641–3644, 1987. PUBMED Abstract
  30. Grun JB, Brinton MA: Characterization of West Nile virus RNA-dependent RNA polymerase and cellular terminal adenylyl and uridylyl transferases in cell-free extracts. J Virol 60(3):1113–1124, 1986. PUBMED Abstract
  31. Lindenbach BD, Thiel H-J, Rice CM: Flaviviridae: the viruses and their replication. In Knipe DM, Howley PM, editors: Fields virology, ed 5, Philadelphia, 2007, Lippincott-Raven, pp 991–1041.
  32. Wu J, Bera AK, Kuhn RJ, et al: Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol 79(16):10268–10277, 2005. PUBMED Abstract
  33. Hayes CG: West Nile virus: Uganda, 1937, to New York City, 1999. Ann N Y Acad Sci 951:25–37, 2001. PUBMED Abstract
  34. Kilpatrick AM, Meola MA, Moudy RM, et al: Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 4(6):e1000092, 2008. PUBMED Abstract
  35. Weaver SC, Reisen WK: Present and future arboviral threats. Antiviral Res 85(2):328–345, 2010. PUBMED Abstract
  36. McLean RG, Ubico SR, Bourne D, et al: West Nile virus in livestock and wildlife. Curr Top Microbiol Immunol 267:271–308, 2002. PUBMED Abstract
  37. Komar N, Panella NA, Boyce E: Exposure of domestic mammals to West Nile virus during an outbreak of human encephalitis, New York City, 1999. Emerg Infect Dis 7(4):736–738, 2001. PUBMED Abstract
  38. Komar N, Lanciotti R, Bowen R, et al: Detection of West Nile virus in oral and cloacal swabs collected from bird carcasses. Emerg Infect Dis 8(7):741–742, 2002. PUBMED Abstract
  39. Komar N, Langevin S, Hinten S, et al: Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 9(3):311–322, 2003. PUBMED Abstract
  40. Hayes EB, Komar N, Nasci RS, et al: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 11(8):1167–1173, 2005. PUBMED Abstract
  41. Investigations of West Nile virus infections in recipients of blood transfusions. Morb Mortal Wkly Rep 51(43):973–974, 2002.
  42. Centers for Disease Control and Prevention: Possible West Nile virus transmission to an infant through breast-feeding—Michigan, 2002. JAMA 288(16):1976–1977, 2002.
  43. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. Morb Mortal Wkly Rep 51(37):833–836, 2002.
  44. Hindiyeh M, Shulman LM, Mendelson E, et al: Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel. Emerg Infect Dis 7(4):748–750, 2001. PUBMED Abstract
  45. Intrauterine West Nile virus infection—New York, 2002. Morb Mortal Wkly Rep 51(50):1135–1136, 2002.
  46. Baqar S, Hayes CG, Murphy JR, et al: Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes. Am J Trop Med Hyg 48(6):757–762, 1993. PUBMED Abstract
  47. Ahmed T, Hayes CG, Baqar S: Comparison of vector competence for West Nile virus of colonized populations of Culex tritaeniorhynchus from southern Asia and the Far East. Southeast Asian J Trop Med Public Health 10(4):498–504, 1979. PUBMED Abstract
  48. Molaei G, Andreadis TG, Armstrong PM, et al: Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Emerg Infect Dis 12(3):468–474, 2006. PUBMED Abstract
  49. Turell MJ, O'Guinn ML, Dohm DJ, et al: Vector competence of North American mosquitoes (Diptera: Culicidae) for West Nile virus. J Med Entomol 38(2):130–134, 2001. PUBMED Abstract
  50. Hadler J, Nelson R, McCarthy T, et al: West Nile virus surveillance in Connecticut in 2000: an intense epizootic without high risk for severe human disease. Emerg Infect Dis 7(4):636–642, 2001. PUBMED Abstract
  51. Kulasekera VL, Kramer L, Nasci RS, et al: West Nile virus infection in mosquitoes, birds, horses, and humans, Staten Island, New York, 2000. Emerg Infect Dis 7(4):722–725, 2001. PUBMED Abstract
  52. Update: Surveillance for West Nile virus in overwintering mosquitoes—New York, 2000. Morb Mortal Wkly Rep 49(9):178–179, 2000.
  53. Komar N: West Nile virus: epidemiology and ecology in North America. Adv Virus Res 61:185–234, 2003. PUBMED Abstract
  54. Hayes CG, Basit A, Bagar S, et al: Vector competence of Culex tritaeniorhynchus (Diptera: Culicidae) for West Nile virus. J Med Entomol 17(2):172–177, 1980. PUBMED Abstract
  55. Sardelis MR, Turell MJ, Dohm DJ, et al: Vector competence of selected North American Culex and Coquillettidia mosquitoes for West Nile virus. Emerg Infect Dis 7(6):1018–1022, 2001. PUBMED Abstract
  56. Mans NZ, Yurgionas SE, Garvin MC, et al: West Nile virus in mosquitoes of Northern Ohio, 2001-2002. Am J Trop Med Hyg 70(5):562–565, 2004. PUBMED Abstract
  57. Reisen WK, Fang Y, Martinez VM: Avian host and mosquito (Diptera: Culicidae) vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission. J Med Entomol 42(3):367–375, 2005. PUBMED Abstract
  58. Turell MJ, O'Guinn ML, Dohm DJ, et al: Vector competence of Culex tarsalis from Orange County, California, for West Nile virus. Vector Borne Zoonotic Dis 2(3):193–196, 2002. PUBMED Abstract
  59. Blackmore CG, Stark LM, Jeter WC, et al: Surveillance results from the first West Nile virus transmission season in Florida, 2001. Am J Trop Med Hyg 69(2):141–150, 2003. PUBMED Abstract
  60. Godsey MS Jr, Blackmore MS, Panella NA, et al: West Nile virus epizootiology in the southeastern United States, 2001. Vector Borne Zoonotic Dis 5(1):82–89, 2005. PUBMED Abstract
  61. Hribar LJ, Vlach JJ, Demay DJ, et al: Mosquitoes infected with West Nile virus in the Florida Keys, Monroe County, Florida, USA. J Med Entomol 40(3):361–363, 2003. PUBMED Abstract
  62. Rutledge CR, Day JF, Lord CC, et al: West Nile virus infection rates in Culex nigripalpus (Diptera: Culicidae) do not reflect transmission rates in Florida. J Med Entomol 40(3):253–258, 2003. PUBMED Abstract
  63. Zyzak M, Loyless T, Cope S, et al: Seasonal abundance of Culex nigripalpus Theobald and Culex salinarius Coquillett in north Florida, USA. J Vector Ecol 27(1):155–162, 2002. PUBMED Abstract
  64. Tesh RB, Parsons R, Siirin M, et al: Year-round West Nile virus activity, Gulf Coast region, Texas and Louisiana. Emerg Infect Dis 10(9):1649–1652, 2004. PUBMED Abstract
  65. Lillibridge KM, Parsons R, Randle Y, et al: The 2002 introduction of West Nile virus into Harris County, Texas, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg 70(6):676–681, 2004. PUBMED Abstract
  66. Sardelis MR, Turell MJ, O'Guinn ML, et al: Vector competence of three North American strains of Aedes albopictus for West Nile virus. J Am Mosq Control Assoc 18(4):284–289, 2002. PUBMED Abstract
  67. Turell MJ, Dohm DJ, Sardelis MR, et al: An update on the potential of north American mosquitoes (Diptera: Culicidae) to transmit West Nile Virus. J Med Entomol 42(1):57–62, 2005. PUBMED Abstract
  68. Trawinski PR, Mackay DS: Identification of environmental covariates of West Nile virus vector mosquito population abundance. Vector Borne Zoonotic Dis 10(5):515–526, 2010. PUBMED Abstract
  69. Niebylski ML, Savage HM, Nasci RS, et al: Blood hosts of Aedes albopictus in the United States. J Am Mosq Control Assoc 10(3):447–450, 1994. PUBMED Abstract
  70. Savage HM, Niebylski ML, Smith GC, et al: Host-feeding patterns of Aedes albopictus (Diptera: Culicidae) at a temperate North American site. J Med Entomol 30(1):27–34, 1993. PUBMED Abstract
  71. Samui KL, Gleiser RM, Hugh-Jones ME, et al: Mosquitoes captured in a horse-baited stable trap in southeast Louisiana. J Am Mosq Control Assoc 19(2):139–147, 2003. PUBMED Abstract
  72. Rochlin I, Ginsberg HS, Campbell SR: Distribution and abundance of host-seeking Culex species at three proximate locations with different levels of West Nile virus activity. Am J Trop Med Hyg 80(4):661–668, 2009. PUBMED Abstract
  73. Molaei G, Andreadis TG: Identification of avian- and mammalian-derived bloodmeals in Aedes vexans and Culiseta melanura (Diptera: Culicidae) and its implication for West Nile virus transmission in Connecticut, USA. J Med Entomol 43(5):1088–1093, 2006. PUBMED Abstract
  74. Anderson JF, Main AJ, Ferrandino FJ, et al: Nocturnal activity of mosquitoes (Diptera: Culicidae) in a West Nile virus focus in Connecticut. J Med Entomol 44(6):1102–1108, 2007. PUBMED Abstract
  75. Bunning ML, Bowen RA, Cropp B, et al: Experimental infection of horses with West Nile virus and their potential to infect mosquitoes and serve as amplifying hosts. Ann N Y Acad Sci 951:338–339, 2001. PUBMED Abstract
  76. Ng T, Hathaway D, Jennings N, et al: Equine vaccine for West Nile virus. Dev Biol (Basel) 114:221–227, 2003. PUBMED Abstract
  77. Anderson JF, Main AJ, Andreadis TG, et al: Transstadial transfer of West Nile virus by three species of ixodid ticks (Acari: Ixodidae). J Med Entomol 40(4):528–533, 2003. PUBMED Abstract
  78. Lawrie CH, Uzcategui NY, Gould EA, et al: Ixodid and argasid tick species and west nile virus. Emerg Infect Dis 10(4):653–657, 2004. PUBMED Abstract
  79. Hutcheson HJ, Gorham CH, Machain-Williams C, et al: Experimental transmission of West Nile virus (Flaviviridae: Flavivirus) by Carios capensis ticks from North America. Vector Borne Zoonotic Dis 5(3):293–295, 2005. PUBMED Abstract
  80. Southam CM, Moore AE: Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg 3(1):19–50, 1954. PUBMED Abstract
  81. Bunning ML, Bowen RA, Cropp CB, et al: Experimental infection of horses with West Nile virus. Emerg Infect Dis 8(4):380–386, 2002. PUBMED Abstract
  82. Austgen LE, Bowen RA, Bunning ML, et al: Experimental infection of cats and dogs with West Nile virus. Emerg Infect Dis 10(1):82–86, 2004. PUBMED Abstract
  83. Kilpatrick AM, Kramer LD, Jones MJ, et al: West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol 4(4):e82, 2006. PUBMED Abstract
  84. Kilpatrick AM, Daszak P, Jones MJ, et al: Host heterogeneity dominates West Nile virus transmission. Proc Biol Sci 273(1599):2327–2333, 2006. PUBMED Abstract
  85. Komar N: West Nile viral encephalitis. Rev Sci Tech 19(1):166–176, 2000. PUBMED Abstract
  86. Pesko KN, Ebel GD: West Nile virus population genetics and evolution. Infect Genet Evol 12(2):181–190, 2012. PUBMED Abstract
  87. Work TH, Hurlbut HS, Taylor RM: Isolation of West Nile virus from hooded crow and rock pigeon in the Nile delta. Proc Soc Exp Biol Med 84(3):719–722, 1953. PUBMED Abstract
  88. Work TH, Hurlbut HS, Taylor RM: Indigenous wild birds of the Nile Delta as potential West Nile virus circulating reservoirs. Am J Trop Med Hyg 4(5):872–888, 1955. PUBMED Abstract
  89. Caffrey CPC: Christmas bird count data suggest West Nile virus may not be a conservation issue in the northeastern United States. American Birds (103rd Count) 14–21, 2004.
  90. Jacobson ER, Ginn PE, Troutman JM, et al: West Nile virus infection in farmed American alligators (Alligator mississippiensis) in Florida. J Wildl Dis 41(1):96–106, 2005. PUBMED Abstract
  91. Heinz-Taheny KM, Andrews JJ, Kinsel MJ, et al: West Nile virus infection in free-ranging squirrels in Illinois. J Vet Diagn Invest 16(3):186–190, 2004. PUBMED Abstract
  92. Kutzler MA, Bildfell RJ, Gardner-Graff KK, et al: West Nile virus infection in two alpacas. J Am Vet Med Assoc 225(6):880, 921–924, 2004. PUBMED Abstract
  93. Yaeger M, Yoon KJ, Schwartz K, et al: West Nile virus meningoencephalitis in a Suri alpaca and Suffolk ewe. J Vet Diagn Invest 16(1):64–66, 2004. PUBMED Abstract
  94. Kecskemeti S, Bajmocy E, Bacsadi A, et al: Encephalitis due to West Nile virus in a sheep. Vet Rec 161(16):568–569, 2007. PUBMED Abstract
  95. Gubler DJ, Campbell GL, Nasci R, et al: West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol 13(4):469–475, 2000. PUBMED Abstract
  96. Update: West Nile virus activity—United States, 2005. Morb Mortal Wkly Rep 54(35):877–878, 2005.
  97. Drebot MA, Artsob H: West Nile virus. Update for family physicians. Can Fam Physician 51:1094–1099, 2005. PUBMED Abstract
  98. Cruz L, Cardenas VM, Abarca M, et al: Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg 72(5):612–615, 2005. PUBMED Abstract
  99. Dauphin G, Zientara S, Zeller H, et al: West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis 27(5):343–355, 2004. PUBMED Abstract
  100. Dupuis AP 2nd, Marra PP, Kramer LD: Serologic evidence of West Nile virus transmission, Jamaica, West Indies. Emerg Infect Dis 9(7):860–863, 2003. PUBMED Abstract
  101. Granwehr BP, Lillibridge KM, Higgs S, et al: West Nile virus: where are we now? Lancet Infect Dis 4(9):547–556, 2004. PUBMED Abstract
  102. Rappole JH, Derrickson SR, Hubalek Z: Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 6(4):319–328, 2000. PUBMED Abstract
  103. Hayes EB, Gubler DJ: West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med 57:181–194, 2006. PUBMED Abstract
  104. Garcia-Bocanegra I, Jaen-Tellez JA, Napp S, et al: Monitoring of the West Nile Virus epidemic in Spain between 2010 and 2011. Transbound Emerg Dis Epub ahead of print 2012. PUBMED Abstract
  105. Romi R, Pontuale G, MG CI, et al: Potential vectors of West Nile virus following an equine disease outbreak in Italy. Med Vet Entomol 18(1):14–19, 2004. PUBMED Abstract
  106. Gingrich JB, Casillas L: Selected mosquito vectors of West Nile virus: comparison of their ecological dynamics in four woodland and marsh habitats in Delaware. J Am Mosq Control Assoc 20(2):138–145, 2004. PUBMED Abstract
  107. Gingrich JB, Williams GM: Host-feeding patterns of suspected West Nile virus mosquito vectors in Delaware, 2001-2002. J Am Mosq Control Assoc 21(2):194–200, 2005. PUBMED Abstract
  108. Cruz-Pacheco G, Esteva L, Montano-Hirose JA, et al: Modelling the dynamics of West Nile Virus. Bull Math Biol 67(6):1157–1172, 2005. PUBMED Abstract
  109. Ward MP: Epidemic West Nile virus encephalomyelitis: a temperature-dependent, spatial model of disease dynamics. Prev Vet Med 71(3–4):253–264, 2005. PUBMED Abstract
  110. Monath TP: Prospects for development of a vaccine against the West Nile virus. Ann N Y Acad Sci 951:1–12, 2001. PUBMED Abstract
  111. Durand B, Chevalier V, Pouillot R, et al: West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. Emerg Infect Dis 8(8):777–782, 2002. PUBMED Abstract
  112. Kramer LD, Bernard KA: West Nile virus infection in birds and mammals. Ann N Y Acad Sci 951:84–93, 2001. PUBMED Abstract
  113. West Nile virus activity—United States, January 1-December 1, 2005. Morb Mortal Wkly Rep 54(49):1253–1256, 2005.
  114. Update: West Nile Virus activity—Eastern United States, 2000. Morb Mortal Wkly Rep 49(46):1044–1047, 2000.
  115. West Nile virus activity—United States, 2006. Morb Mortal Wkly Rep 56(22):556–559, 2007.
  116. Petersen LR, Marfin AA: West Nile virus: a primer for the clinician. Ann Intern Med 137(3):173–179, 2002. PUBMED Abstract
  117. Weiss D, Carr D, Kellachan J, et al: Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 7(4):654–658, 2001. PUBMED Abstract
  118. Salazar P, Traub-Dargatz JL, Morley PS, et al: Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J Am Vet Med Assoc 225(2):267–274, 2004. PUBMED Abstract
  119. Schuler LA, Khaitsa ML, Dyer NW, et al: Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J Am Vet Med Assoc 225(7):1084–1089, 2004. PUBMED Abstract
  120. Rios LM, Sheu JJ, Day JF, et al: Environmental risk factors associated with West Nile virus clinical disease in Florida horses. Med Vet Entomol 23(4):357–366, 2009. PUBMED Abstract
  121. Epp T, Waldner C, West K, et al: Factors associated with West Nile virus disease fatalities in horses. Can Vet J 48(11):1137–1145, 2007. PUBMED Abstract
  122. Ostlund E, Crom R, Thomson E: West Nile virus: epidemiology, pathogeneis, immunologic response. American College of Veterinary Internal Medicine Forum 2002.
  123. Porter MB, Long MT, Getman LM, et al: West Nile virus encephalomyelitis in horses: 46 cases, 2001. J Am Vet Med Assoc 222(9):1241–1247, 2003. PUBMED Abstract
  124. Cantile C, Del Piero F, Di Guardo G, et al: Pathologic and immunohistochemical findings in naturally occuring West Nile virus infection in horses. Vet Pathol 38(4):414–421, 2001. PUBMED Abstract
  125. Snook CS, Hyman SS, Del Piero F, et al: West Nile virus encephalomyelitis in eight horses. J Am Vet Med Assoc 218(10):1576–1579, 2001. PUBMED Abstract
  126. Cantile C, Di Guardo G, Eleni C, et al: Clinical and neuropathological features of West Nile virus equine encephalomyelitis in Italy. Equine Vet J 32(1):31–35, 2000. PUBMED Abstract
  127. Desai A, Shankar SK, Ravi V, et al: Japanese encephalitis virus antigen in the human brain and its topographic distribution. Acta Neuropathol 89(4):368–373, 1995. PUBMED Abstract
  128. Rosemberg S: Neuropathology of S. Paulo south coast epidemic encephalitis (Rocio flavivurus). J Neurol Sci 45(1):1–12, 1980. PUBMED Abstract
  129. Joubert L, Oudar J, Hannoun C, et al: Experimental reproduction of meningo-encephalomyelitis of horses with West Nile arbovirus. 3. Relations between virology, serology, and anatomo-clinical evolution. Epidemiological and prophylactic consequences. Bull Acad Vet Fr 44(3):159–167, 1971. PUBMED Abstract
  130. Oudar J, Joubert L, Lapras M, et al: Experimental reproduction of meningo-encephalomyelitis of horses with West Nile arbovirus. II. Anatomo-clinical study. Bull Acad Vet Fr 44(3):147–158, 1971. PUBMED Abstract
  131. Tamalet J, Toga M, Chippaux-Hyppolite C, et al: Experimental encephalitis caused by West-Nile virus in mice: ultrastructural aspects of the central nervous system. C R Acad Sci Hebd Seances Acad Sci D 269(5):668–671, 1969. PUBMED Abstract
  132. Gilroy J: Basic neurology, New York, 1992, McGraw-Hill.
  133. Guillon JC, Oudar J, Joubert L, et al: Histological lesions of the nervous system in West Nile virus infection in horses. Ann Inst Pasteur Paris 114(4):539–550, 1968. PUBMED Abstract
  134. Tiroumourougane SV, Raghava P, Srinivasan S: Japanese viral encephalitis. Postgrad Med J 78(918):205–215, 2002. PUBMED Abstract
  135. Ostlund EN, Crom RL, Pedersen DD, et al: Equine West Nile encephalitis, United States. Emerg Infect Dis 7(4):665–669, 2001. PUBMED Abstract
  136. Joubert L, Oudar J, Hannoun C, et al: Epidemiology of the West Nile virus: study of a focus in Camargue. IV. Meningo-encephalomyelitis of the horse. Ann Inst Pasteur Paris 118(2):239–247, 1970. PUBMED Abstract
  137. Ogata A, Tashiro K, Nukuzuma S, et al: A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol 3(2):141–147, 1997. PUBMED Abstract
  138. Asher DM: Movement disorders in rhesus monkeys after infection with tick-borne encephalitis virus. Adv Neurol 10:277–289, 1975. PUBMED Abstract
  139. Mayhew I: Large animal neurology, Philadelphia, 1989, Lea & Febiger.
  140. Monath TP, Cropp CB, Harrison AK: Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest 48(4):399–410, 1983. PUBMED Abstract
  141. Diamond MS, Klein RS: West Nile virus: crossing the blood-brain barrier. Nat Med 10(12):1294–1295, 2004. PUBMED Abstract
  142. Wang T, Town T, Alexopoulou L, et al: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10(12):1366–1373, 2004. PUBMED Abstract
  143. Sbrana E, Tonry JH, Xiao SY, et al: Oral transmission of West Nile virus in a hamster model. Am J Trop Med Hyg 72(3):325–329, 2005. PUBMED Abstract
  144. Tonry JH, Xiao SY, Siirin M, et al: Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg 72(3):320–324, 2005. PUBMED Abstract
  145. Xiao SY, Guzman H, Zhang H, et al: West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 7(4):714–721, 2001. PUBMED Abstract
  146. Ostlund EN, Andresen JE, Andresen M: West Nile encephalitis. Vet Clin North Am Equine Pract 16(3):427–441, 2000. PUBMED Abstract
  147. Shrestha B, Gottlieb D, Diamond MS: Infection and injury of neurons by West Nile encephalitis virus. J Virol 77(24):13203–13213, 2003. PUBMED Abstract
  148. Mayer V, Rajcani J: Study of the virulence of tick-borne encephalitis virus. VI. Intracerebral infection of monkeys with clones experimentally attenuated virus. Acta Virol 11(4):321–333, 1967. PUBMED Abstract
  149. Haahr S: The occurrence of virus and interferon in spleen, serum and brain in steroi-treated mice under experimental infection with West Nile virus. Acta Pathol Microbiol Scand 75(2):303–312, 1969. PUBMED Abstract
  150. Halevy M, Akov Y, Ben-Nathan D, et al: Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch Virol 137(3-4):355–370, 1994. PUBMED Abstract
  151. Myint KS, Raengsakulrach B, Young GD, et al: Production of lethal infection that resembles fatal human disease by intranasal inoculation of macaques with Japanese encephalitis virus. Am J Trop Med Hyg 60(3):338–342, 1999. PUBMED Abstract
  152. Wang H, Siddharthan V, Hall JO, et al: West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters. J Neurovirol 15(4):293–299, 2009. PUBMED Abstract
  153. Morrey JD, Siddharthan V, Wang H, et al: West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons. J Neurovirol 14(2):152–163, 2008. PUBMED Abstract
  154. Samuel MA, Wang H, Siddharthan V, et al: Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A 104(43):17140–17145, 2007. PUBMED Abstract
  155. Onomoto K, Onoguchi K, Takahasi K, et al: Type I interferon production induced by RIG-I-like receptors. J Interferon Cytokine Res 30(12):875–881, 2010. PUBMED Abstract
  156. Diamond MS, Gale M Jr: Cell-intrinsic innate immune control of West Nile virus infection. Trends Immunol 33(10):522–530, 2012. PUBMED Abstract
  157. Davis EG, Zhang Y, Tuttle J, et al: Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine. Vet Immunol Immunopathol 126(3-4):293–301, 2008. PUBMED Abstract
  158. Daffis S, Szretter KJ, Schriewer J, et al: 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468(7322):452–456, 2010. PUBMED Abstract
  159. Samuel MA, Whitby K, Keller BC, et al: PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80(14):7009–7019, 2006. PUBMED Abstract
  160. Jiang D, Weidner JM, Qing M, et al: Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 84(16):8332–8341, 2010. PUBMED Abstract
  161. Samuel MA, Diamond MS: Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79(21):13350–13361, 2005. PUBMED Abstract
  162. Bourgeois MA, Denslow ND, Seino KS, et al: Gene expression analysis in the thalamus and cerebrum of horses experimentally infected with West Nile virus. PLoS One 6(10):e24371, 2011. PUBMED Abstract
  163. Yoneyama M, Fujita T: Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20(1):4–22, 2010. PUBMED Abstract
  164. Rodrigues L, Nandakumar S, Bonorino C, et al: IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Mol Immunol 46(7):1494–1504, 2009. PUBMED Abstract
  165. Rodrigues L, Bonorino C: Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies. Expert Rev Vaccines 8(2):167–177, 2009. PUBMED Abstract
  166. Barbic L, Listes E, Katic S, et al: Spreading of West Nile virus infection in Croatia. Vet Microbiol 159(3-4):504–508, 2012. PUBMED Abstract
  167. Samuel MA, Diamond MS: Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80(19):9349–9360, 2006. PUBMED Abstract
  168. Wang T, Fikrig E: Immunity to West Nile virus. Curr Opin Immunol 16(4):519–523, 2004. PUBMED Abstract
  169. Bai F, Kong KF, Dai J, et al: A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis 202(12):1804–1812, 2010. PUBMED Abstract
  170. Lim JK, Murphy PM: Chemokine control of West Nile virus infection. Exp Cell Res 317(5):569–574, 2011. PUBMED Abstract
  171. Klein RS, Lin E, Zhang B, et al: Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79(17):11457–11466, 2005. PUBMED Abstract
  172. Maximova OA, Faucette LJ, Ward JM, et al: Cellular inflammatory response to flaviviruses in the central nervous system of a primate host. J Histochem Cytochem 57(10):973–989, 2009. PUBMED Abstract
  173. Blakely PK, Kleinschmidt-DeMasters BK, Tyler KL, et al: Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol 68(10):1061–1072, 2009. PUBMED Abstract
  174. Darman J, Backovic S, Dike S, et al: Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci 24(34):7566–7575, 2004. PUBMED Abstract
  175. Erdmann NB, Whitney NP, Zheng J: Potentiation of excitotoxicity in HIV-1 associated dementia and the significance of glutaminase. Clin Neurosci Res 6(5):315–328, 2006. PUBMED Abstract
  176. Verma S, Molina Y, Lo YY, et al: In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol J 5:66, 2008. PUBMED Abstract
  177. Shrestha B, Diamond MS: Role of CD8+ T cells in control of West Nile virus infection. J Virol 78(15):8312–8321, 2004. PUBMED Abstract
  178. Wang Y, Lobigs M, Lee E, et al: CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77(24):13323–13334, 2003. PUBMED Abstract
  179. Johnson HL, Chen Y, Jin F, et al: CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J Immunol; 189(4):1937–1945, 2012. PUBMED Abstract
  180. Takashima I: Japanese encephalitis. In OIE Standards Commission, editors: Manual of standards for diagnostic test and vaccines, ed 4, Paris, 2001, OIE, pp 607–614.
  181. Gould DJ, Byrne RJ, Hayes DE: Experimental infection of horses with japanese encephalitis virus by mosquito bites. Am J Trop Med Hyg 13:742–746, 1964. PUBMED Abstract
  182. Grosenbaugh DA, Backus CS, Karaca K, et al: The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine. Vet Ther 5(4):251–257, 2004. PUBMED Abstract
  183. Guthrie AJ, Howell PG, Gardner IA, et al: West Nile virus infection of Thoroughbred horses in South Africa (2000-2001). Equine Vet J 35(6):601–605, 2003. PUBMED Abstract
  184. Pantheir R, Hannoun C, Oudar J, et al: Isolation of West Nile virus in a Camarge horse with encephalomyelitis. C R Acad Sci Hebd Seances Acad Sci D 262(11):1308–1310, 1966. PUBMED Abstract
  185. Wang H, Siddharthan V, Hall JO, et al: Autonomic nervous dysfunction in hamsters infected with West Nile virus. PLoS One 6(5):e19575, 2011. PUBMED Abstract
  186. Wilson JH: Long term effects of West Nile virus in horses. In Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners (AAEP), 2005.
  187. Porter MB, Long M, Gosche DG, et al: Immunoglobulin M-capture enzyme-linked immunosorbent assay testing of cerebrospinal fluid and serum from horses exposed to West Nile virus by vaccination or natural infection. J Vet Intern Med 18(6):866–870, 2004. PUBMED Abstract
  188. Wamsley HL, Alleman AR, Porter MB, et al: Findings in cerebrospinal fluids of horses infected with West Nile virus: 30 cases (2001). J Am Vet Med Assoc 221(9):1303–1305, 2002. PUBMED Abstract
  189. Cernescu C, Ruta SM, Tardei G, et al: A high number of severe neurologic clinical forms during an epidemic of West Nile virus infection. Rom J Virol 48(1-4):13–25, 1997. PUBMED Abstract
  190. Jeha LE, Sila CA, Lederman RJ, et al: West Nile virus infection: a new acute paralytic illness. Neurology 61(1):55–59, 2003. PUBMED Abstract
  191. Long MT, Jeter W, Hernandez J, et al: Diagnostic performance of the equine IgM capture ELISA for serodiagnosis of West Nile virus infection. J Vet Intern Med 20(3):608–613, 2006. PUBMED Abstract
  192. Davidson AH, Traub-Dargatz JL, Rodeheaver RM, et al: Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J Am Vet Med Assoc 226(2):240–245, 2005. PUBMED Abstract
  193. Sanchez MD, Pierson TC, McAllister D, et al: Characterization of neutralizing antibodies to West Nile virus. Virology 336(1):70–82, 2005. PUBMED Abstract
  194. Balasuriya UB, Shi PY, Wong SJ, et al: Detection of antibodies to West Nile virus in equine sera using microsphere immunoassay. J Vet Diagn Invest 18(4):392–395, 2006. PUBMED Abstract
  195. Johnson DJ, Ostlund EN, Pedersen DD, et al: Detection of North American West Nile virus in animal tissue by a reverse transcription-nested polymerase chain reaction assay. Emerg Infect Dis 7(4):739–741, 2001. PUBMED Abstract
  196. Tewari D, Kim H, Feria W, et al: Detection of West Nile virus using formalin fixed paraffin embedded tissues in crows and horses: quantification of viral transcripts by real-time RT-PCR. J Clin Virol 30(4):320–325, 2004. PUBMED Abstract
  197. Pennick KE, McKnight CA, Patterson JS, et al: Diagnostic sensitivity and specificity of in situ hybridization and immunohistochemistry for Eastern equine encephalitis virus and West Nile virus in formalin-fixed, paraffin-embedded brain tissue of horses. J Vet Diagn Invest 24(2):333–338, 2012. PUBMED Abstract
  198. Kolman JM: Serologic examination of some domestic animals from South Moravia on the presence of antibodies to selected arboviruses of the A, B, California and Bunyamwera groups. Folia Parasitol (Praha) 20(4):353–360, 1973. PUBMED Abstract
  199. Bonaduce A, Compagnucci M, Bonaduce D, et al: Studies on the occurrence and distribution of HI antibodies against some arboviruses in the serum of domestic mammals in Puglia. Folia Vet Lat 7(2):145–157, 1977. PUBMED Abstract
  200. Matsumura T, Goto H, Shimizu K, et al: Prevalence and distribution of antibodies to Getah and Japanese encephalitis viruses in horses raised in Hokkaido. Nihon Juigaku Zasshi 44(6):967–970, 1982. PUBMED Abstract
  201. Shirafuji H, Kanehira K, Kamio T, et al: Antibody responses induced by experimental West Nile virus infection with or without previous immunization with inactivated Japanese encephalitis vaccine in horses. J Vet Med Sci 71(7):969–974, 2009. PUBMED Abstract
  202. Scholle F, Mason PW: West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology 342(1):77–87, 2005. PUBMED Abstract
  203. Anderson JF, Rahal JJ: Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 8(1):107–108, 2002. PUBMED Abstract
  204. Engle MJ, Diamond MS: Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice. J Virol 77(24):12941–12949, 2003. PUBMED Abstract
  205. Leis AA, Stokic DS: Neuromuscular manifestations of human West Nile virus infection. Curr Treat Options Neurol 7(1):15–22, 2005. PUBMED Abstract
  206. Roos KL: West Nile encephalitis and myelitis. Curr Opin Neurol 17(3):343–346, 2004. PUBMED Abstract
  207. Jackson AC: Therapy of West Nile virus infection. Can J Neurol Sci 31(2):131–134, 2004. PUBMED Abstract
  208. Overstreet M: Patient education series. West Nile virus. Nursing 35(8):64, 2005. PUBMED Abstract
  209. Romero JR, Newland JG: Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 14(2):72–82, 2003. PUBMED Abstract
  210. Crom R: Update on current status of West Nile virus: Equine cases of West Nile virus infection in 2001: 1 January through 20 November. U.S. Department of Agriculture. Animal and Plant Health Inspection Service 2001.
  211. Crom R: Update on current status of West Nile virus. U.S. Department of Agriculture. Animal and Plant Health Inspection Service 2002.